Statins use in intracerebral hemorrhage patients.


This is a study involving participants who have been on a stable regimen of statins, a class of medications used to lower cholesterol levels, who have been admitted to the hospital with intracerebral hemorrhage (ICH). ICH is a type of bleeding that occurs around the brain. It has been proposed that the use of statins may increase the risk of ICH recurrence, and genetics may also play a role in this. This study is a multi-center, randomized trial that will compare continuing the use of statins versus discontinuation of statins and how this may affect the likelihood of ICH happening again. A genetic marker will also be analyzed to study its effect on ICH recurrence. A total of 1,456 participants will be enrolled in the United States.


  • National Institute of Neurological Disorders and Stroke, a subdivision of the National Institute of Health.

Principal Investigator